Profile
Henning Weigt worked as Head-Quality Control at LipoNova AG from 2004 to 2007.
He then worked as a Principal at Fraunhofer-Gesellschaft eV, followed by a position as Project Manager & Head-Quality Assurance at Vakzine Projekt Management GmbH from 2007 to 2014.
Weigt received his undergraduate degree from the University of Hannover in 1999.
Former positions of Henning Weigt
| Companies | Position | End |
|---|---|---|
LipoNova AG
 LipoNova AG Medical/Nursing ServicesHealth Services The Company's principal activity is drug development. The Company is developer of effective therapies for diseases such as non-metastatic renal cell carcinoma (RCC). The Company also develops autologous tumour vaccines. | Corporate Officer/Principal | 2006-12-31 |
Fraunhofer-Gesellschaft eV
 Fraunhofer-Gesellschaft eV Miscellaneous Commercial ServicesCommercial Services Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. operates as an application-oriented research organization. The firm focuses on health, security, communication, as well as environment and energy. It develops technology, designs products, and improves methods and techniques. The company was founded on March 26, 1949 and is headquartered in Munich, Germany. | Corporate Officer/Principal | - |
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Chief Operating Officer | - |
Training of Henning Weigt
| University of Hannover | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
LipoNova AG
LipoNova AG Medical/Nursing ServicesHealth Services The Company's principal activity is drug development. The Company is developer of effective therapies for diseases such as non-metastatic renal cell carcinoma (RCC). The Company also develops autologous tumour vaccines. | Health Services |
Fraunhofer-Gesellschaft eV
Fraunhofer-Gesellschaft eV Miscellaneous Commercial ServicesCommercial Services Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. operates as an application-oriented research organization. The firm focuses on health, security, communication, as well as environment and energy. It develops technology, designs products, and improves methods and techniques. The company was founded on March 26, 1949 and is headquartered in Munich, Germany. | Commercial Services |
- Stock Market
- Insiders
- Henning Weigt
